Home > News > The IPO Market's Golden Mean?
August 9th, 2004
The IPO Market's Golden Mean?
Venture capitalists have argued that many nanotech concerns, like biotechs before them, will come to the public markets early in their lifetimes because their work is so capital-intensive that they'll need the kind of resources only Wall Street can provide. But so far, the market isn't ready to bet aggressively on early-stage research many institutional investors barely grasp.
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
Harris & Harris Group Invests in Unique NYC Biotech Accelerator July 29th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
Nanometrics Announces Upcoming Investor Events July 22nd, 2014